the rapid hydrolysis of cefamandole nafate to cefamandole in vivo , combined with the partial hydrolysis of cefamandole nafate in vitro before administration ( caused by na2co3 in the formulation ) , resulted in circulating levels of cefamandole nafate lower than those of cefamandole .
C0054995
cefamandole
C0007541
cefamandole